hqh113 2022-03-10

Leading journal in the field of enteritis. In the past, it mainly consisted of clinical papers, but gradually started to include some basic research. Due to the frequent publication of highly cited IBD guidelines, the impact factor is expected to stabilize at around 10 points in the future. Based on my submission experience, I feel that this journal treats Chinese researchers comparatively well and it is worth considering if there are good results.